-- £

Cozaar is the brand name for losartan, a prescription medication in the ARB (angiotensin II receptor blocker) family—used to treat high blood pressure and, in certain patients, to help reduce the risk of stroke and protect the kidneys. What makes losartan historically interesting is that it was one of the first ARBs widely adopted in modern cardiology, offering a different approach from ACE inhibitors by blocking angiotensin II at its receptor—an option many patients ask about, especially if they’ve had issues like the persistent cough some people experience on ACE inhibitors.

On iMedix, the Cozaar page is designed to feel like a clear, confidence-building guide rather than a wall of medical text. You’ll quickly understand what Cozaar is prescribed for, who it’s meant to help, and what “lowering blood pressure” really means in terms of real-life outcomes. The page also covers one of Cozaar’s most searched topics: its role in type 2 diabetes with diabetic kidney disease (in appropriate patients), where it’s used to help slow progression in people with protein in the urine—something many patients only learn about after they’ve already been worried by lab results.

Because Cozaar is a long-term medication for many people, the practical details matter. iMedix explains what patients commonly notice (and what they usually don’t “feel” at all), how dosing and timing are typically approached by clinicians, and the everyday issues that come up—missed doses, blood pressure checks, and why consistency often matters more than perfection. It also covers the side effects and safety points people actually need to know: dizziness (especially when starting or adjusting), potassium levels, kidney function monitoring in some cases, and the situations where extra caution is important.

If you want a straightforward overview that’s easy to read and still medically grounded, the iMedix Cozaar page brings the key facts together in one place—so you can understand the medication, ask smarter questions at your appointment, and feel more in control of your next steps. This content is informational and not medical advice.

Source notes (not part of the listing): Cozaar FDA labeling indications include hypertension, stroke risk reduction in hypertension with LVH, and diabetic nephropathy in type 2 diabetes. Losartan’s U.S. approval date (1995) and “first ARB” context are supported by NIH LiverTox and early clinical literature.